{
    "id": "185bba8c-5048-4e2f-8b98-97537c04a982",
    "indications": "poteligeo indicated treatment adult patients relapsed refractory mycosis fungoides ( mf ) sézary syndrome ( ss ) least one prior systemic therapy .",
    "contraindications": "1 mg/kg intravenous infusion least 60 minutes days 1 , 8 , 15 , 22 first 28-day cycle days 1 15 subsequent cycle ( 2 ) .",
    "warningsAndPrecautions": "poteligeo ( mogamulizumab-kpkc ) injection sterile , preservative-free , clear slightly opalescent colorless solution supplied carton containing one 20 mg/5 ml ( 4 mg/ml ) , single-dose glass vial ( ndc 42747-761-01 ) .",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "mogamulizumab",
            "code": "YI437801BE"
        },
        {
            "name": "citric acid monohydrate",
            "code": "2968PHW8QP"
        },
        {
            "name": "glycine",
            "code": "TE7660XO1C"
        },
        {
            "name": "polysorbate 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "sodium hydroxide",
            "code": "55X04QC32I"
        },
        {
            "name": "hydrochloric acid",
            "code": "QTT17582CB"
        },
        {
            "name": "water",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "Kyowa Kirin, Inc.",
    "name": "POTELIGEO",
    "effectiveTime": "20250506",
    "indications_original": "POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.",
    "contraindications_original": "1 mg/kg as an intravenous infusion over at least 60 minutes on days 1, 8, 15, and 22 of the first 28-day cycle and on days 1 and 15 of each subsequent cycle ( 2 ).",
    "warningsAndPrecautions_original": "POTELIGEO (mogamulizumab-kpkc) injection is a sterile, preservative-free, clear to slightly opalescent colorless solution supplied in a carton containing one 20 mg/5 mL (4 mg/mL), single-dose glass vial (NDC 42747-761-01).",
    "adverseReactions_original": "None."
}